USPharmacisthttp://www.uspharmacist.comUSPharmacist:generic_trendsGenerics Will Have Modest Negative Impact on Hypertension Drug Market Sales Through 2018http://www.uspharmacist.com/content/d/generic_trends/c/16508/11/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/16508/Consumers Worldwide Favor Generic Drugshttp://www.uspharmacist.com/content/d/generic_trends/c/15820/9/21/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/15820/Erosion of Branded Dyslipidemia Drug Sales Likelyhttp://www.uspharmacist.com/content/d/generic_trends/c/15824/9/21/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/15824/FTC Questions Years of Patent Protection for Biotech Drugshttp://www.uspharmacist.com/content/d/generic_trends/c/15822/9/21/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/15822/Greenstone Announces Key Management Appointmentshttp://www.uspharmacist.com/content/d/generic_trends/c/15823/9/21/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/15823/Deal Finalized Between Sepracor and Teva on Xopenexhttp://www.uspharmacist.com/content/d/generic_trends/c/13449/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13449/FDA Amends Ban on Unapproved Opioidshttp://www.uspharmacist.com/content/d/generic_trends/c/13443/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13443/FDA Approves Generic Topamaxhttp://www.uspharmacist.com/content/d/generic_trends/c/13444/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13444/GPhA Applauds Approval of Patent Reform Acthttp://www.uspharmacist.com/content/d/generic_trends/c/13454/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13454/GPhA Endorses Availability of Biogenericshttp://www.uspharmacist.com/content/d/generic_trends/c/13445/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13445/Mylan Files ANDA for Chemo Drug; Sued by Rochehttp://www.uspharmacist.com/content/d/generic_trends/c/13453/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13453/Mylan Settles With Schering-Plough Over Clarinexhttp://www.uspharmacist.com/content/d/generic_trends/c/13450/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13450/Prasco to Market and Distribute GSK Genericshttp://www.uspharmacist.com/content/d/generic_trends/c/13451/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13451/Teva Launches Two New Producthttp://www.uspharmacist.com/content/d/generic_trends/c/13452/5/19/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/13452/Dr. Reddy's Launches Five New Genericshttp://www.uspharmacist.com/content/d/generic_trends/c/12637/3/18/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/12637/Generics Blamed for Cut in Glaxo Jobshttp://www.uspharmacist.com/content/d/generic_trends/c/12638/3/18/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/12638/Lannett Patents New Manufacturing Method for Morphine Derivativeshttp://www.uspharmacist.com/content/d/generic_trends/c/12641/3/18/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/12641/Proposed Bill to Stop Generic Drug Delayshttp://www.uspharmacist.com/content/d/generic_trends/c/12635/3/18/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/12635/Teva and Lonza Partner on Biosimilarshttp://www.uspharmacist.com/content/d/generic_trends/c/12640/3/18/2009 9:00:00 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/12640/Generic Trendshttp://www.uspharmacist.com/content/d/generic_trends/c/11773/GPhA Congratulates President-Elect Obama In congratulating Senator Obama on his election win, Kathleen Jaeger, president and CEO of the Generic Pharmaceutical Association (GPhA), said that Obama and the new Congress "must now tackle the serious challenges facing our economy, including rising health care costs" by increasing access to "affordable generic and biogeneric medicines.12/15/2008 9:10:25 AMhttp://www.uspharmacist.com/content/d/generic_trends/c/11773/Generic Trendshttp://www.uspharmacist.com/content/d/generic_trends/c/10987/FDA Sends Ranbaxy Warning Letters; Import Alert Issued The FDA has sent two Warning Letters to Ranbaxy Laboratories, Ltd.10/17/2008 2:39:23 PMhttp://www.uspharmacist.com/content/d/generic_trends/c/10987/